Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(10%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
7
70%
Ph phase_2
2
20%

Phase Distribution

0

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
2(22.2%)
N/ANon-phased studies
7(77.8%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(9)

Detailed Status

Completed9
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 22 (22.2%)
N/A7 (77.8%)

Trials by Status

recruiting110%
completed990%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
10